药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Pirbuterol
Ledipasvir
The serum concentration of Ledipasvir can be increased when it is combined with Mirabegron.
Pirbuterol
Edoxaban
The serum concentration of Edoxaban can be increased when it is combined with Mirabegron.
Pirbuterol
Afatinib
The serum concentration of Afatinib can be increased when it is combined with Mirabegron.
Glisoxepide
Oliceridine
The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Arbaclofen Placarbil is combined with Oliceridine.
Glisoxepide
Remimazolam
The risk or severity of sedation can be increased when Arbaclofen Placarbil is combined with Remimazolam.
Glisoxepide
Magnesium
Magnesium can cause a decrease in the absorption of Arbaclofen Placarbil resulting in a reduced serum concentration and potentially a decrease in efficacy.
Glisoxepide
Lasmiditan
The risk or severity of adverse effects can be increased when Arbaclofen Placarbil is combined with Lasmiditan.
Glisoxepide
Benzhydrocodone
The risk or severity of respiratory depression can be increased when Benzhydrocodone is combined with Arbaclofen Placarbil.
Glisoxepide
Nicomorphine
The risk or severity of respiratory depression can be increased when Nicomorphine is combined with Arbaclofen Placarbil.
Glisoxepide
Eluxadoline
The risk or severity of respiratory depression can be increased when Eluxadoline is combined with Arbaclofen Placarbil.
Glisoxepide
Bezitramide
The risk or severity of respiratory depression can be increased when Bezitramide is combined with Arbaclofen Placarbil.
Glisoxepide
Esketamine
The risk or severity of adverse effects can be increased when Arbaclofen Placarbil is combined with Esketamine.
Glisoxepide
Cannabinol
The risk or severity of adverse effects can be increased when Cannabinol is combined with Arbaclofen Placarbil.
Glisoxepide
Palmidrol
The risk or severity of adverse effects can be increased when Palmidrol is combined with Arbaclofen Placarbil.
Glisoxepide
Nabiximols
The risk or severity of adverse effects can be increased when Nabiximols is combined with Arbaclofen Placarbil.
Glisoxepide
WIN 55212-2
The risk or severity of adverse effects can be increased when WIN 55212-2 is combined with Arbaclofen Placarbil.
Glisoxepide
Surinabant
The risk or severity of adverse effects can be increased when Surinabant is combined with Arbaclofen Placarbil.
Glisoxepide
Ibipinabant
The risk or severity of adverse effects can be increased when Ibipinabant is combined with Arbaclofen Placarbil.
Glisoxepide
Ajulemic acid
The risk or severity of adverse effects can be increased when Ajulemic acid is combined with Arbaclofen Placarbil.
Glisoxepide
GW842166
The risk or severity of adverse effects can be increased when GW842166 is combined with Arbaclofen Placarbil.